
Bioorganic and Medicinal Chemistry p. 661 - 672 (1997)
Update date:2022-08-02
Topics:
Wang, Ruo
Steensma, Darryl H.
Takaoka, Yoshikazu
Yun, Joanne W.
Kajimoto, Tetsuya
Wong, Chi-Huey
The design and synthesis of several β-1,4-galactosyltransferase inhibitors are reported. Mimics of the pyrophosphate-Mn2+ complex were the focus of the design. Malonic, tartaric, and monosaccharide moieties were used as replacements of the pyrophosphate moiety, and galactose or azasugars with potent galactosidase inhibitory activity were used as the 'donor' component. Compound 6, in which glucose was used as the pyrophosphate-Mn2+ complex mimic and galactose as the 'donor' component, showed the best inhibitory activity towards the transferase with a K(i) of 119.6 μM.
View MoreShijiazhuang Haotian Chemical Co., Ltd.
Contact:86-311-85044374
Address:293 Donggang Road
Contact:+86-533-3112891
Address:zibo
Shanghai Dano Pharmaceutical Co.,Ld.(expird)
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
Contact:+86 512 6287 2180
Address:398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu, P. R. China
Zhejiang Golden-Shell Pharmaceutical Co.,Ltd.
Contact:+86-576-87501888 / 87501988
Address:No.89 Zhongxing Road. Li'ao, Yuhuan, Zhejiang, China
Doi:10.1016/j.ejmech.2015.03.044
(2015)Doi:10.1007/s11164-020-04160-5
(2020)Doi:10.1055/s-2002-19759
(2002)Doi:10.1021/ic010202b
(2002)Doi:10.1002/anie.201712618
(2018)Doi:10.1002/adsc.201500703
(2016)